Use access key #2 to skip to page content.
$5.71 -0.19 (-3.22%)
9/4/2008 4:00 PM

Exelixis, Inc. (EXEL)

CAPS Rating:
*****

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases.

View All Commentary (EXEL)

Recs

2

Avatar TMFselzhanik (98.89) Submitted: 4/25/07 11:37 AM : Outperform Start Price: $8.85 EXEL Score: -27.43

My unborn daughter had some fantastic points about the stock:
http://www.votigo.com/contests/showentry/2985

Despite my concerns that they are bleeding cash at $10 million per month, she assures me that the expenses are primarily going into R&D, and they've got a deep pipeline of cancer drugs, with 7 in phase 1 and 2 trials. News could come soon about those trials, and if the news is good, the price could soar.

Later, she told me that she had been studying my Rule Breakers issues. Gasp! I hide those in my nightstand -- I didn't think she knew about them!

Report this Post Replies: 0 | Reply

Featured Broker Partners